9 01, 2024

Nurturing Complexity: The role of vascularization in Organoid Advancements

2024-01-09T11:27:37+00:00January 9th, 2024|Blog, organoid news|

Organoids are exciting models that are rapidly becoming a hopeful platform for many medical advances such as drug screening and disease modeling. However, due to a lack of vascularization, they have limitations for future applications. This review blog summarizes several practical methods for successful organoid vascularization to date.

7 12, 2023

Pep Talk 7th December 2023

2023-12-14T10:15:34+00:00December 7th, 2023|newsletter, Resources|

This edition highlights some of our latest resources and products. These include our high-purity mouse/rat Noggin, our newly launched Flt3L (Qk087) to our growing hematopoietic stem cell range and our latest blog on liver organoids emerging as a transformative model for malaria drug discovery.

6 12, 2023

Considerations for the use of high-purity recombinant growth factors in cellular agriculture applications

2024-01-05T13:37:53+00:00December 6th, 2023|Blog, cellular agriculture|

Cultivated meat is a nascent industry with a developing regulatory framework, with distinct regional differences. There are however some shared themes across regulatory frameworks and best practice. Within the UK and EU, cultivated meat is considered a novel food and as such falls under the scope of Regulation (EU) No. 2015/2283. In response to this classification, the Food Safety Agency commissioned an internal report into the potential hazards to the consumer associated with the production and consumption of cultured meat. Following a literature review of 154 papers discussing cultured meat as a technology, themes that apply to growth factors have been highlighted and discussed.

30 11, 2023

Hepatocyte-derived organoids provide unique insights into liver cell invasion by malaria parasites

2024-01-05T13:39:37+00:00November 30th, 2023|Blog, organoid news|

Complex 3D liver models that more closely mimic human biology open opportunities for improved drug and vaccine discovery for malaria and related parasitic diseases.

23 11, 2023

Pep Talk 23rd November 2023

2023-11-23T12:00:36+00:00November 23rd, 2023|newsletter, Resources|

This edition highlights some of our latest resources and products. These include a case study comparing mTESR, Stem Flex and media containing Qkine thermostable FGF2-G3 (Qk053), our high purity CNTF, and newly launched GM-CSF (Qk076) to our growing hematopoietic stem cell range. We are also excited to announce a new distribution agreement in the US with Thomas Scientific and a 30% discount for new customers for three months.

24 10, 2023

Pep Talk 24th October 2023

2023-10-24T10:18:09+00:00October 24th, 2023|newsletter, Resources|

To support customers working on neural stem cells and glial cells, we have launched CNTF which is animal-free and highly bioactive for improved reproducibility in neural stem cell cultures. We have linked some useful resources, including a new neural on-demand webinar on ‘Advancements in Neurobiology Modeling’. Finally, learn about the first of our on-site stocking partnerships which allow customers same-day access to our products to provide the best and fastest service possible.


Go to Top